Consolidated income statement

          2013 2012
      Note   DKK million DKK million
                     
    Revenue       2.1, 2.2   11,746  11,234 
    Cost of goods sold     2.3, 4.1, 4.2   5,030  4,811 
    Gross profit             6,716  6,423 
                     
    Sales and distribution costs     2.3, 4.1, 4.2   1,476  1,421 
    Research and development costs     2.3, 4.1, 4.2   1,528  1,527 
    Administrative costs   2.3, 4.1, 4.2, 6.5   824  808 
    Other operating income, net         2.4   13  78 
    Operating profit / EBIT             2,901  2,745 
                     
    Financial income         5.1   82  22 
    Financial costs         5.1   224  183 
    Profit before tax             2,759  2,584 
                     
    Tax         4.6   558  568 
    Net profit             2,201  2,016 
                     
    Attributable to                
    Shareholders in Novozymes A/S             2,200  2,015 
    Non-controlling interests            
                  2,201  2,016 
                     
    Proposed dividend per share             DKK 2.50 DKK 2.20
                     
    Earnings per share         6.7   DKK 7.01 DKK 6.42
    Earnings per share, diluted         6.7   DKK 6.93 DKK 6.33